Literature DB >> 7590822

Immunologic mechanisms and therapy in multiple sclerosis.

D A Hafler1, H L Weiner.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7590822     DOI： 10.1111/j.1600-065x.1995.tb00066.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  27 in total

1.  Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.

Authors:  H Fukaura; S C Kent; M J Pietrusewicz; S J Khoury; H L Weiner; D A Hafler
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 2.  Special regulatory T-cell review: Regulatory T cells and the intestinal tract--patrolling the frontier.

Authors:  Ana Izcue; Fiona Powrie
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

Review 3.  Cytokine-induced inflammation in the central nervous system revisited.

Authors:  J A Martiney; C Cuff; M Litwak; J Berman; C F Brosnan
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2.

Authors:  A Weishaupt; R Gold; S Gaupp; G Giegerich; H P Hartung; K V Toyka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

5.  Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.

Authors:  C Beeton; H Wulff; J Barbaria; O Clot-Faybesse; M Pennington; D Bernard; M D Cahalan; K G Chandy; E Béraud
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

Authors:  Paolo A Muraro; Klaus-Peter Wandinger; Bibiana Bielekova; Bruno Gran; Adriana Marques; Ursula Utz; Henry F McFarland; Steve Jacobson; Roland Martin
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

Review 7.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

8.  Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment.

Authors:  S Brocke; C Piercy; L Steinman; I L Weissman; T Veromaa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

9.  Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.

Authors:  L Shinto; G Marracci; S Baldauf-Wagner; A Strehlow; V Yadav; L Stuber; D Bourdette
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-01-25       Impact factor: 4.006

10.  A randomized pilot study of naturopathic medicine in multiple sclerosis.

Authors:  Lynne Shinto; Carlo Calabrese; Cynthia Morris; Vijayshree Yadav; Debbie Griffith; Rachel Frank; Barry S Oken; Sara Baldauf-Wagner; Dennis Bourdette
Journal:  J Altern Complement Med       Date:  2008-06       Impact factor: 2.579
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.